Washington D.C. is getting ready for an exciting year full of fresh travel experiences that will change how people explore ...

Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...

Omeros on Wednesday said the approval covers Yartemlea for patients ages 2 and older with hematopoietic stem-cell transplant-associated thrombotic microangiopathy, a complication driven by the ...

YARTEMLEA is approved by the U.S. FDA for the treatment of TA-TMA in adults and in children ages two years and older. A marketing authorization application for YARTEMLEA for TA-TMA is under review by ...

Performances in N.Y.C. Advertisement Supported by A holiday album that cuts through seasonal glut, a late collaboration by Jim McNeely and Helmut Lachenmann’s string quartets are among the highlights.

Meeting the needs of the community is one of North Idaho College President Nick Swayne’s main goals. So when he saw a growing trend toward classical education in the Inland Northwest with charter, ...

Wildfire smoke causes more air pollution than current atmospheric models can predict. A new study by researchers at King Abdullah University of Science and Technology (KAUST) and the Chinese Academy ...

Good afternoon, and welcome to today's earnings call for Omeros Corporation. [Operator Instructions] Please be advised this call is being recorded at the company's request, and a replay will be ...

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Cell-free biocatalysis is a rapidly evolving field with great potential for ...